Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Aggregation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| TDP-43 | causes | protein | 1.00 |
| TAU | involved_in | protein | 0.98 |
| TDP-43 | involved_in | protein | 0.95 |
| 21209826 | is required (though not sufficient) for | paper | 0.90 |
| 21209826 | is required, though not sufficient, for | paper | 0.90 |
| SNCA | involved_in | protein | 0.90 |
| C-terminal truncations | accelerates | protein | 0.70 |
| 21209826 | is required for | paper | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Endothelial CD2AP knockdown effects on memory in male mice | validation | Alzheimer's disease | 0.900 | 0.00 | male mice | proposed | N/A |
| Amyloid plaque load analysis in triple-mutant mouse brains | exploratory | Alzheimer's disease | 0.880 | 0.00 | APP/PSEN1/GD3S-/- triple-trans | proposed | N/A |
| Reelin treatment rescue via ApoER2 in CD2AP mutant mice | validation | Alzheimer's disease | 0.870 | 0.00 | mice | proposed | N/A |
| MRI Phenotyping Method Concordance in Serbian AD Cohort | clinical | Alzheimer's disease | 0.850 | 0.00 | human patients | proposed | N/A |
| Endothelin-1 receptor A antagonist rescue in male CD2AP mice | validation | Alzheimer's disease | 0.850 | 0.00 | male mice | proposed | N/A |
| Endothelin-1 receptor A antagonist rescue experiment | validation | Alzheimer's disease | 0.850 | 0.00 | mice | proposed | N/A |
| In vivo BBB transport of LPS-carrying bEVs | validation | Alzheimer's disease | 0.850 | 0.00 | mice | proposed | N/A |
| Neuroimmune modulation and Aβ clearance mechanisms | exploratory | Alzheimer's disease | 0.820 | 0.00 | Microglia and astrocytes | proposed | N/A |
| 16S rRNA sequencing of gut microbiome in PH-PS treated mice | exploratory | Alzheimer's disease | 0.800 | 0.00 | 5×FAD transgenic mice | proposed | N/A |
| Competing endogenous RNA (ceRNA) network construction | exploratory | Alzheimer's disease | 0.750 | 0.00 | computational network analysis | proposed | N/A |
| s:** - Dose-response studies showing therapeutic window without toxici | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Alpha-Synuclein SAA Kinetics Study — Biological Staging Backbone for P | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiation Mechanis | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Computational Modeling of Alpha-Synuclein Propagation in PD | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,280,000 |
| Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,730,000 |
| Alpha-Synuclein Seed Amplification Assay Validation | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,500,000 |
| Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation and Neuro | exploratory | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,070,000 |
| Antiviral Therapy Trial for Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Combination Therapy Sequencing in Parkinson's Disease | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,280,000 |
| Alpha-Synuclein Staging and Spreading in DLB — Spatial Propagation Map | validation | Parkinson's Disease | 0.400 | 0.50 | cell_line | proposed | $160,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] | ["Han X", "Sun S", "Sun Y", "Song Q", "Z | Autophagy | 2020 | 1 |
| Gigantol: a principal bioactive constituent of Dendrobium species-multi-target m [PMID:40939944] | Shi S, Zhu C, Xu J, Sui Q, Zhu S, Zhang | Journal of ethnopharmacology | 2026 | 0 |
| Biomimetic cancer cell membrane-coated liposomal nanocarriers loaded with silibi [PMID:41585438] | Yao J, Sun Q, Zhang X, Yang D, Wu H et a | Mater Today Bio | 2026 | 0 |
| Exploring synergistic therapeutic potential of Erlotinib and artemisinin in non- [PMID:41672289] | Suleman F, Khan T, Alshehade SA, Ali M, | Clin Chim Acta | 2026 | 0 |
| Methyl-4-hydroxybenzoate induces osteoporosis via the AKT1/LC3B/Beclin1 autophag [PMID:41740552] | Fu F, Wang W, Li Y, Shi S, Huang J, Liu | Ecotoxicology and environmenta | 2026 | 0 |
| Chronic Thermal Stress During Early Zebrafish (Danio rerio) Development Induces [PMID:41793424] | Adzijovski M, Schultz AG, Oxley APA, Ber | Fish physiology and biochemist | 2026 | 0 |
| α-Glucosidase inhibitor: identifying key targets and mechanisms in type 2 diabet [PMID:41907120] | Garg SS, Vijh D, Gupta P, Gupta J, Malik | 3 Biotech | 2026 | 0 |
| Elucidating the mechanisms of aristolochic acid-induced upper tract urothelial c [PMID:41780445] | Liu T, Yao Y, Xu Y, Zhang H, Sun L, Zhan | Computational biology and chem | 2026 | 0 |
| A Study on the Mechanism of Acetyl Tributyl Citrate-Induced Infertility Toxicity [PMID:41898778] | Sun X, Chen P, Han Y, Du Y, Sun S, Miu J | International journal of molec | 2026 | 0 |
| Investigating the clinical efficacy, safety and molecular mechanism of sulforaph [PMID:41275316] | Long J, Liao X, Tang Z, Han K, Chen J, W | BMC pharmacology & toxicology | 2025 | 0 |
| Cerebrospinal fluid HSP90AA1, HSPA4, and STUB1/CHIP levels in Alzheimer's diseas [PMID:40116694] | Sordu P, Alaylıoğlu M, Samancı B, Bulu E | J Alzheimers Dis | 2025 | 0 |
| The chaperones HSP90AA1, HSP90AB1 and BAG3 are specifically distributed among hu [PMID:40436281] | Soriano-Herrador C, Ubeda-Banon I, Villa | Neurobiol Dis | 2025 | 0 |
| Mapping the pathogenic nexus: Gene overlap and protein interaction networks in A [PMID:40973403] | Chowdhury MR, Deepa VS, Raja VK | Adv Protein Chem Struct Biol | 2025 | 0 |
| Utility of Drosophila for studying hypoxia-inducible factor (HIF) in neurodegene [PMID:40976499] | Serebrovska Z, Xi L, Khetsuriani M, Prot | Brain research | 2025 | 0 |
| The mechanism of probiotics in pregnancy outcomes in overweight or obese pregnan [PMID:40859213] | Zhong T, Sun J, Miao M, Sun G | BMC pregnancy and childbirth | 2025 | 0 |
| Revisiting Parkinson's disease definition and classification: insights from two [PMID:40906256] | ["Reyes N", "Pajo A", "Saranza G", "H\u0 | Journal of neural transmission | 2025 | 0 |
| Chrysotoxine regulates ferroptosis and the PI3K/AKT/mTOR pathway to prevent cerv [PMID:39557107] | Zhou J, Guo Z, Peng X, Wu B, Meng Q, Lu | Journal of ethnopharmacology | 2025 | 0 |
| Advancing Parkinson's diagnosis: seed amplification assay for α-synuclein detect [PMID:39760833] | ["Carrazana E", "Montalb\u00e1n-Guti\u00 | Molecular and cellular biochem | 2025 | 0 |
| MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell mo [PMID:40367191] | ["Wang H", "Wang Q", "Xu H", "Wu Y", "Ch | Science translational medicine | 2025 | 0 |
| Uncovering injury-specific proteomic signatures and neurodegenerative risks in s [PMID:40545497] | ["Mantash S", "Aboulouard S", "Dakik H", | Signal transduction and target | 2025 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
Hypotheses and analyses mentioning Aggregation in their description or question text
Score: 0.551 · Alzheimer's Disease · 2026-04-02
## **Molecular Mechanism and Rationale** The heat shock protein 90 (HSP90) chaperone system represents a critical cellu
Score: 0.511 · neurodegeneration · 2026-04-02
Specific gut bacterial strains produce short-chain fatty acids (SCFAs) that cross the blood-brain barrier and directly m
Score: 0.500 · molecular biology · 2026-04-21
## Mechanistic Overview Nucleolar p21-rRNA Co-Aggregation as Irreversible Senescence Gate starts from the claim that mod
Score: 0.490 · neurodegeneration · 2026-04-22
## Mechanistic Overview G3BP1-TDP-43 Cross-Seeding Drives Co-Aggregation That Prion-Spreads Across Neural Circuits start
Score: 0.429 · neurodegeneration · 2026-04-18
## Mechanistic Overview GSK3β Inhibition to Prevent α-Synuclein Phosphorylation and Aggregation starts from the claim th
Score: 0.423 · neurodegeneration · 2026-04-22
## Mechanistic Overview P2X7/P2Y12 Purinergic Signaling Connects Aβ Aggregation to SPP1 Transcription via Calcineurin/NF
Score: 0.390 · neurodegeneration · 2026-04-25
Cystatin C binds tau through its cystatin-like domain, sequestering monomeric tau and preventing β-sheet aggregation. Th
Score: 0.360 · neurodegeneration · 2026-04-21
## Mechanistic Overview Direct APOE4-TDP-43 Protein-Protein Interaction Promoting Aggregation Seeding starts from the cl
Score: 0.105 · molecular biology · 2026-04-18
## Mechanistic Overview Alectinib's Putative C1q Binding Derives from Hydrophobic Aggregation Rather Than Direct Protein